MedTrace Logo

Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?

NCT05102396 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2024-05-28

No results posted yet for this study

Summary

The TODAY trial is a study to evaluate the efficacy and safety of topical oxybutynin deodorant for use in patients with axillary hyperhidrosis.

Conditions

  • Hyperhidrosis
  • Oxybutynin
  • Sweat Gland Diseases
  • Skin Diseases
  • Autonomic Agents
  • Cholinergic Antagonists
  • Parasympatholytics

Interventions

DRUG

Topical oxybutynin spray

Participants will receive topical oxybutynin spray (10%).

DRUG

Topical placebo spray

Participants will receive topical placebo spray.

DRUG

Oral oxybutynin

Participants will receive oxybutynin (tablets).

Sponsors & Collaborators

  • Science Valley Research Institute

    collaborator OTHER

  • Samantha Rodrigues Camargo Neves de Moura

    lead OTHER

Principal Investigators

  • Eduardo Ramacciotti, MD, PhD · Science Valley Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-26
Primary Completion
2024-06-30
Completion
2024-08-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05102396 on ClinicalTrials.gov